Skip to main content
FinSpry Logo
FinSpry
ACTU logo
ACTU
(NASDAQ)
Actuate Therapeutics, Inc.
$2.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Actuate Therapeutics (ACTU) Stock Price & Financial Analysis

Actuate Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.34 - $2.60
52-Week High$11.99
52-Week Low$2.05
Open$2.46
Volume42.81K
Average Volume (3M)42.81K
Market Cap53.06M
Shares Outstanding21.39M
Price to Book (P/B)4.87
EV/EBITDA-1.51
50-Day MA$3.68
200-Day MA$6.14
52-Week Change-62.84%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Actuate Therapeutics

What is the current stock price for ACTU?

As of the latest trading session, ACTU stock trades at $2.48. The 52-week range is $2.05–$11.99, with a day range of $2.33–$2.60.

What is the P/E ratio for ACTU?

The P/E ratio (Price-to-Earnings) for ACTU is shown in the Key Statistics section. This valuation metric helps compare Actuate Therapeutics, Inc. to industry peers.

Does ACTU pay dividends?

Actuate Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ACTU?

Analyst ratings and recommendations for ACTU are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ACTU?

Actuate Therapeutics's market capitalization is $53.1M, classifying it as a micro-cap company. Actuate Therapeutics operates in the Healthcare sector within the Biotechnology industry.